281 related articles for article (PubMed ID: 38223537)
1. Systematic development of ionizable lipid nanoparticles for placental mRNA delivery using a design of experiments approach.
Young RE; Nelson KM; Hofbauer SI; Vijayakumar T; Alameh MG; Weissman D; Papachristou C; Gleghorn JP; Riley RS
Bioact Mater; 2024 Apr; 34():125-137. PubMed ID: 38223537
[TBL] [Abstract][Full Text] [Related]
2. Lipid Nanoparticle Composition Drives mRNA Delivery to the Placenta.
Young RE; Nelson KM; Hofbauer SI; Vijayakumar T; Alameh MG; Weissman D; Papachristou C; Gleghorn JP; Riley RS
bioRxiv; 2022 Dec; ():. PubMed ID: 36597546
[TBL] [Abstract][Full Text] [Related]
3. EGFR-targeted ionizable lipid nanoparticles enhance in vivo mRNA delivery to the placenta.
Geisler HC; Ghalsasi AA; Safford HC; Swingle KL; Thatte AS; Mukalel AJ; Gong N; Hamilton AG; Han EL; Nachod BE; Padilla MS; Mitchell MJ
J Control Release; 2024 Jul; 371():455-469. PubMed ID: 38789090
[TBL] [Abstract][Full Text] [Related]
4. Ionizable Lipid Nanoparticles for
Swingle KL; Safford HC; Geisler HC; Hamilton AG; Thatte AS; Billingsley MM; Joseph RA; Mrksich K; Padilla MS; Ghalsasi AA; Alameh MG; Weissman D; Mitchell MJ
J Am Chem Soc; 2023 Mar; 145(8):4691-4706. PubMed ID: 36789893
[TBL] [Abstract][Full Text] [Related]
5. Chemistry of Lipid Nanoparticles for RNA Delivery.
Eygeris Y; Gupta M; Kim J; Sahay G
Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635
[TBL] [Abstract][Full Text] [Related]
6. Orthogonal Design of Experiments for Engineering of Lipid Nanoparticles for mRNA Delivery to the Placenta.
Safford HC; Swingle KL; Geisler HC; Hamilton AG; Thatte AS; Ghalsasi AA; Billingsley MM; Alameh MG; Weissman D; Mitchell MJ
Small; 2023 Aug; ():e2303568. PubMed ID: 37537704
[TBL] [Abstract][Full Text] [Related]
7. Helper lipid structure influences protein adsorption and delivery of lipid nanoparticles to spleen and liver.
Zhang R; El-Mayta R; Murdoch TJ; Warzecha CC; Billingsley MM; Shepherd SJ; Gong N; Wang L; Wilson JM; Lee D; Mitchell MJ
Biomater Sci; 2021 Feb; 9(4):1449-1463. PubMed ID: 33404020
[TBL] [Abstract][Full Text] [Related]
8. Bile acid-containing lipid nanoparticles enhance extrahepatic mRNA delivery.
Patel SK; Billingsley MM; Mukalel AJ; Thatte AS; Hamilton AG; Gong N; El-Mayta R; Safford HC; Merolle M; Mitchell MJ
Theranostics; 2024; 14(1):1-16. PubMed ID: 38164140
[TBL] [Abstract][Full Text] [Related]
9. Ionizable lipid nanoparticles encapsulating barcoded mRNA for accelerated in vivo delivery screening.
Guimaraes PPG; Zhang R; Spektor R; Tan M; Chung A; Billingsley MM; El-Mayta R; Riley RS; Wang L; Wilson JM; Mitchell MJ
J Control Release; 2019 Dec; 316():404-417. PubMed ID: 31678653
[TBL] [Abstract][Full Text] [Related]
10. Lipid nanoparticle-based mRNA candidates elicit potent T cell responses.
Zeng Y; Escalona-Rayo O; Knol R; Kros A; Slütter B
Biomater Sci; 2023 Jan; 11(3):964-974. PubMed ID: 36537916
[TBL] [Abstract][Full Text] [Related]
11. Influence of ionizable lipid tail length on lipid nanoparticle delivery of mRNA of varying length.
Mrksich K; Padilla MS; Joseph RA; Han EL; Kim D; Palanki R; Xu J; Mitchell MJ
J Biomed Mater Res A; 2024 Mar; ():. PubMed ID: 38487970
[TBL] [Abstract][Full Text] [Related]
12. A fluorinated ionizable lipid improves the mRNA delivery efficiency of lipid nanoparticles.
Huo H; Cheng X; Xu J; Lin J; Chen N; Lu X
J Mater Chem B; 2023 May; 11(19):4171-4180. PubMed ID: 37129135
[TBL] [Abstract][Full Text] [Related]
13. Substituting racemic ionizable lipids with stereopure ionizable lipids can increase mRNA delivery.
Da Silva Sanchez AJ; Zhao K; Huayamares SG; Hatit MZC; Lokugamage MP; Loughrey D; Dobrowolski C; Wang S; Kim H; Paunovska K; Kuzminich Y; Dahlman JE
J Control Release; 2023 Jan; 353():270-277. PubMed ID: 36423872
[TBL] [Abstract][Full Text] [Related]
14. Intracellular trafficking kinetics of nucleic acid escape from lipid nanoparticles via fluorescence imaging.
M Bailey-Hytholt C; Ulinski G; Dugas J; Haines M; Lazebnik M; Piepenhagen P; E Zarraga I; Bandekar A
Curr Pharm Biotechnol; 2023 Apr; ():. PubMed ID: 37016519
[TBL] [Abstract][Full Text] [Related]
15. Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways.
Tam A; Kulkarni J; An K; Li L; Dorscheid DR; Singhera GK; Bernatchez P; Reid G; Chan K; Witzigmann D; Cullis PR; Sin DD; Lim CJ
Eur J Pharm Sci; 2022 Sep; 176():106234. PubMed ID: 35688311
[TBL] [Abstract][Full Text] [Related]
16. Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing.
El-Mayta R; Padilla MS; Billingsley MM; Han X; Mitchell MJ
J Vis Exp; 2023 Jan; (191):. PubMed ID: 36744791
[TBL] [Abstract][Full Text] [Related]
17. Investigations into mRNA Lipid Nanoparticles Shelf-Life Stability under Nonfrozen Conditions.
Reinhart AG; Osterwald A; Ringler P; Leiser Y; Lauer ME; Martin RE; Ullmer C; Schumacher F; Korn C; Keller M
Mol Pharm; 2023 Dec; 20(12):6492-6503. PubMed ID: 37975733
[TBL] [Abstract][Full Text] [Related]
18. Optimization of DOTAP/chol Cationic Lipid Nanoparticles for mRNA, pDNA, and Oligonucleotide Delivery.
Sun M; Dang UJ; Yuan Y; Psaras AM; Osipitan O; Brooks TA; Lu F; Di Pasqua AJ
AAPS PharmSciTech; 2022 May; 23(5):135. PubMed ID: 35534697
[TBL] [Abstract][Full Text] [Related]
19. Analytical Characterization of Heterogeneities in mRNA-Lipid Nanoparticles Using Sucrose Density Gradient Ultracentrifugation.
Vaidya A; Parande D; Khadse N; Vargas-Montoya N; Agarwal V; Ortiz C; Ellis G; Kaushal N; Sarode A; Karve S; DeRosa F
Anal Chem; 2024 Apr; 96(14):5570-5579. PubMed ID: 38529613
[TBL] [Abstract][Full Text] [Related]
20. Tailored Monoacyl Poly(2-oxazoline)- and Poly(2-oxazine)-Lipids as PEG-Lipid Alternatives for Stabilization and Delivery of mRNA-Lipid Nanoparticles.
He X; Payne TJ; Takanashi A; Fang Y; Kerai SD; Morrow JP; Al-Wassiti H; Pouton CW; Kempe K
Biomacromolecules; 2024 Jun; ():. PubMed ID: 38918933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
